Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Fang Zhou, Jingwei Zhang, Peng Li, Fang Niu, Xiaolan Wu, Guangji Wang & Michael S. Roberts. (2011) Toward a new age of cellular pharmacokinetics in drug discovery. Drug Metabolism Reviews 43:3, pages 335-345.
Read now
Read now
Articles from other publishers (16)
Sven de Mey, Inès Dufait & Mark De Ridder. (2021) Radioresistance of Human Cancers: Clinical Implications of Genetic Expression Signatures. Frontiers in Oncology 11.
Crossref
Crossref
Robin A. Fairhurst, Thomas Knoepfel, Nicole Buschmann, Catherine Leblanc, Robert Mah, Milen Todorov, Pierre Nimsgern, Sebastien Ripoche, Michel Niklaus, Nicolas Warin, Van Huy Luu, Mario Madoerin, Jasmin Wirth, Diana Graus-Porta, Andreas Weiss, Michael Kiffe, Markus Wartmann, Jacqueline Kinyamu-Akunda, Dario Sterker, Christelle Stamm, Flavia Adler, Alexandra Buhles, Heiko Schadt, Philippe Couttet, Jutta Blank, Inga Galuba, Jörg Trappe, Johannes Voshol, Nils Ostermann, Chao Zou, Jörg Berghausen, Alberto Del Rio Espinola, Wolfgang Jahnke & Pascal Furet. (2020) Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4. Journal of Medicinal Chemistry 63:21, pages 12542-12573.
Crossref
Crossref
Genevieve Hartley, Robyn Elmslie, Brent Murphy, Leone Hopkins, Amanda Guth & Steven Dow. (2018) Cancer stem cell populations in lymphoma in dogs and impact of cytotoxic chemotherapy. Veterinary and Comparative Oncology 17:1, pages 69-79.
Crossref
Crossref
Hyuk Soo Eun, Sang Yeon Cho, Byung Seok Lee, Sup Kim, In-Sang Song, Kwangsik Chun, Cheong-Hae Oh, Min-Kyung Yeo, Seok Hyun Kim & Kyung-Hee Kim. (2019) Cytochrome P450 4A11 expression in tumor cells: A favorable prognostic factor for hepatocellular carcinoma patients. Journal of Gastroenterology and Hepatology 34:1, pages 224-233.
Crossref
Crossref
Atziri Corin Chavez Alvarez, Mitra Zarifi Khosroshahi, Marie-France Côté, Mathieu Gagné-Boulet & Sébastien Fortin. (2018) 4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamides as new antimitotic prodrugs activated by cytochrome P450 1A1 in breast cancer cells. Bioorganic & Medicinal Chemistry 26:18, pages 5045-5052.
Crossref
Crossref
Xiaojing Ren, Yuanyuan Ji, Xuhua Jiang & Xun Qi. (2018) Downregulation of CYP2A6 and CYP2C8 in Tumor Tissues Is Linked to Worse Overall Survival and Recurrence-Free Survival from Hepatocellular Carcinoma. BioMed Research International 2018, pages 1-9.
Crossref
Crossref
Yan Li, Albert Steppi, Yidong Zhou, Feng Mao, Philip Craig Miller, Max M. He, Tingting Zhao, Qiang Sun & Jinfeng Zhang. (2017) Tumoral expression of drug and xenobiotic metabolizing enzymes in breast cancer patients of different ethnicities with implications to personalized medicine. Scientific Reports 7:1.
Crossref
Crossref
Volkan KARACAOĞLAN, Ahmet Oğuz ADA, Serdar BİLGEN, Guzide Tuğba ÇETİNKAYA, Emre SOYDAŞ, Celalettin Semih KUNAK, Sibel Meryem ALPAR, Meral GÜLHAN & Mümtaz İŞCAN. (2017) Xenobiotic/drug metabolizing enzyme and TP53 polymorphisms and clinical outcome in advanced nonsmall cell lung cancer patients. TURKISH JOURNAL OF MEDICAL SCIENCES 47, pages 554-562.
Crossref
Crossref
Xiangming Guan. 2016. Drug Delivery. Drug Delivery
383
434
.
Elisa M Noll, Christian Eisen, Albrecht Stenzinger, Elisa Espinet, Alexander Muckenhuber, Corinna Klein, Vanessa Vogel, Bernd Klaus, Wiebke Nadler, Christoph Rösli, Christian Lutz, Michael Kulke, Jan Engelhardt, Franziska M Zickgraf, Octavio Espinosa, Matthias Schlesner, Xiaoqi Jiang, Annette Kopp-Schneider, Peter Neuhaus, Marcus Bahra, Bruno V Sinn, Roland Eils, Nathalia A Giese, Thilo Hackert, Oliver Strobel, Jens Werner, Markus W Büchler, Wilko Weichert, Andreas Trumpp & Martin R Sprick. (2016) CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma. Nature Medicine 22:3, pages 278-287.
Crossref
Crossref
Tongmeng Yan, Linlin Lu, Cong Xie, Jiamei Chen, Xiaojuan Peng, Lijun Zhu, Ying Wang, Qiang Li, Jian Shi, Fuyuan Zhou, Ming Hu & Zhongqiu Liu. (2015) Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients. Molecular Cancer Therapeutics 14:12, pages 2874-2886.
Crossref
Crossref
Maurice Zandvliet & Erik Teske. (2015) Mechanisms of Drug Resistance in Veterinary Oncology— A Review with an Emphasis on Canine Lymphoma. Veterinary Sciences 2:3, pages 150-184.
Crossref
Crossref
Ewa Augustin, Magdalena Niemira, Adam Hołownia & Zofia Mazerska. (2014) CYP3A4-dependent cellular response does not relate to CYP3A4-catalysed metabolites of C-1748 and C-1305 acridine antitumor agents in HepG2 cells. Cell Biology International 38:11, pages 1291-1303.
Crossref
Crossref
Claudia Cerella, Cyril Sobolewski, Sébastien Chateauvieux, Estelle Henry, Michael Schnekenburger, Jenny Ghelfi, Mario Dicato & Marc Diederich. (2011) COX-2 inhibitors block chemotherapeutic agent-induced apoptosis prior to commitment in hematopoietic cancer cells. Biochemical Pharmacology 82:10, pages 1277-1290.
Crossref
Crossref
Graeme I Murray, Siva Patimalla, Keith N Stewart, Iain D Miller & Steven D Heys. (2010) Profiling the expression of cytochrome P450 in breast cancer. Histopathology 57:2, pages 202-211.
Crossref
Crossref
Michiko Sugawara, Kiyoshi Okamoto, Tadashi Kadowaki, Kazutomi Kusano, Akiyoshi Fukamizu & Tsutomu Yoshimura. (2010) Expressions of Cytochrome P450, UDP-Glucuronosyltranferase, and Transporter Genes in Monolayer Carcinoma Cells Change in Subcutaneous Tumors Grown As Xenografts in Immunodeficient Nude Mice. Drug Metabolism and Disposition 38:3, pages 526-533.
Crossref
Crossref